Self-testing or self-management of anticoagulation was better than clinic monitoring for thromboembolism and mortality

Leong, Wendy A.
March 2008
ACP Journal Club;Mar/Apr2008, Vol. 148 Issue 2, p21
Academic Journal
The article focuses on 16 randomized controlled trials (RCTs) and 8 non-RCTs investigating if patient self-testing (PST) or self-management (PSM) of oral anticoagulant therapy is more effective than clinic monitoring for anticoagulation control. Trials found out that PST or PSM of anticoagulation may improve anticoagulation control more than primary care-based monitoring and reduces thromboembolic outcomes.


Related Articles

  • Population pharmacokinetics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in atrial fibrillation patients receiving long-term anticoagulation therapy. Bååthe, Sofie; Hamrén, Bengt; Karlsson, Mats O.; Wollbratt, Maria; Grind, Margaretha; Eriksson, Ulf G.; Bååthe, Sofie; Hamrén, Bengt // Clinical Pharmacokinetics;2006, Vol. 45 Issue 8, p803 

    Background: Ximelagatran is an oral direct thrombin inhibitor for the prevention of thromboembolic disease. After oral administration, ximelagatran is rapidly absorbed and bioconverted to its active form, melagatran.Objective: To characterise the pharmacokinetics of...

  • Pentasaccharides: a New Class of Anticoagulants in Clinical Practice. Abdel-Razeq, Hikmat // Journal of Coagulation Disorders;2010, Vol. 2 Issue 2, p1 

    Venous thromboembolism (VTE) remains a common but preventable disease. Increasing focus on simplicity and efficacy has led to the introduction of a new group of anticoagulants, the synthetic pentasaccharides, substances that specifically inhibit factor Xa activity, producing an antithrombotic...

  • Performance Evaluation of a New Small-Volume Coagulation Monitor: The SmartCheck INR System. Chris Gardiner; Ian Longair; Jennifer Hills; Hannah Cohen; Ian Mackie // American Journal of Clinical Pathology;Mar2008, Vol. 129 Issue 3, p500 

    The SmartCheck INR (Unipath, Bedford, England) is a point-of-care device for professional and patient self-monitoring of oral anticoagulant therapy. It measures the international normalized ratio (INR) and assesses test strip integrity, temperature, and sample quality. No significant differences...

  • Largest Warfarin Patient Self-Testing Study Results Establish New Standard of Care.  // Biomedical Market Newsletter;3/28/2012, Vol. 21, p1 

    The article informs about Alere Inc.'s declaration of results of from the world's largest study of warfarin patient self-testers, performed by anticoagulation expert, Jack Ansell, which showed that self-testing led to excellent therapy control. It mentions that warfarin has been used in the U.S....

  • Commentary. Crowther, Mark // Evidence Based Medicine;Apr2007, Vol. 12 Issue 2, p45 

    The article expresses the author's view on the publication of the study on the risk factors that predict recurrent venous thromboembolism (VTE). The author mentions that the issue on the optimal duration of oral coagulation therapy is still being debated because of its risk, the benefit ratio of...

  • Evidence-Based Medicine Requires Appropriate Clinical Context. McNutt, Robert A.; Livingston, Edward H. // JAMA: Journal of the American Medical Association;2/3/2010, Vol. 303 Issue 5, p454 

    The authors comment on a study which examined the occurrence of venous thromboembolism (VTE) in patients with a single negative whole-leg compression ultrasound (CUS) result who did not receive anticoagulation. The meta-analysis of 7 studies, published within the issue, suggests that withholding...

  • ASPIRE: Using Aspirin to Prevent Recurrence of VTE. Buckley, Rita // MD Conference Express;Dec2012, p13 

    The articel discusses the results from the Aspirin to Prevent Recurrent Venous Thromboembolism (ASPIRE) trial by Timothy Brighton. The trial is a double-blind, randomized, placebo-controlled study that evaluates the effectiveness of low-dose aspirin compared to placebo in preventing a recurrence...

  • Venous Thromboembolic (VTE) Prophylaxis: Part II. Goldstein, Perry C. // MEDSURG Nursing;Jul/Aug2015 Newsletter Skin Care Pocket Guide, p9 

    The article focuses on the challenges in the treatment of acute bleeding events and the development of new thrombin and factor Xa inhibitor antidotes for venous thromboembolic (VTE) prophylaxis. Topics discussed include the studies investigating antidotes for the new oral anticoagulants (NOACs),...

  • Self-monitoring of oral anticoagulation: does it work outside trial conditions? C Gardiner // Journal of Clinical Pathology;Feb2009, Vol. 62 Issue 2, p168 

    BACKGROUND: Patient self-monitoring (PSM) of oral anticoagulation therapy (OAT) can improve anticoagulant control, but poor uptake and high dropout rates have prompted suggestions that PSM is suitable for only a minority of patients in the UK. AIMS: To determine whether PSM could be a viable...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics